InsidersTradesSigma
Browse the full record of transactions filed by CARLO DENNIS J PHD, Chairman & CEO. Officer active across 1 companies, notably Adamis Pharmaceuticals Corp. Aggregated, 4 reports have been recorded. Total volume traded: €72k. The latest transaction was disclosed on 18 March 2022 (Cession). Regulator: SEC (Form 4). All data is openly available.
4 of 4 declarations
CARLO DENNIS J PHD is the President and CEO of Adamis Pharmaceuticals Corp. He oversees the company's operations and leads research and development efforts to create innovative treatments in the pharmaceutical field.